DC Chemicals — Chemicals for Life Science
← DC67298 product / Instructions for Use
PRODUCT USE GUIDE · DC67298

Lipid 5D8

Instructions for Use

Download PDFView product

Product information

Lipid 5D8 is a novel biodegradable ionizable lipid (IL) developed through a combinatorial chemistry strategy to overcome the limitations of conventional lipid nanoparticles (LNPs) in mRNA delivery. Synthesized via a one-step, solvent-free Michael addition reaction between amine and thiol monomers, 5D8 features asymmetric lipid tails and a biodegradable ester backbone, ensuring both structural versatility and reduced toxicity. In preclinical studies, 5D8-based LNPs demonstrated exceptional liver-targeting efficiency and mRNA delivery performance. A single intravenous dose (1 mg/kg) achieved 61% CRISPR-Cas9-mediated editing of the TTR gene in mice, reducing serum TTR protein by 90%, outperforming benchmark lipids like C12-200 (51% editing). Moreover, 5D8 enabled efficient delivery of base editors (ABE8.8 and CBE4max), achieving 42% PCSK9 editing (74% serum protein reduction) and correcting hereditary tyrosinemia in mice, significantly extending survival. Beyond gene editing, 5D8 LNPs effectively delivered siRNA (complete serum TTR clearance at 0.05 mg/kg) and enhanced hepatocyte targeting by enriching apolipoprotein E on particle surfaces. Crucially, 5D8 exhibited superior biocompatibility with no hepatotoxicity (normal ALT/AST levels), contrasting traditional LNPs. Its rapid biodegradability and "plug-and-play" design make 5D8 a versatile platform for mRNA therapeutics, holding broad potential for treating genetic disorders, cardiovascular diseases, and beyond. This innovation represents a critical advancement toward safer, high-efficiency clinical translation of gene-editing therapies.L

CAS No.Not available
Chemical NameLipid 5D8
FormulaC48H93O8N3
M.Wt840.28
Purity>98%
StorageOriginal product: up to 1 year under the storage conditions stated on the vial, kept tightly sealed. Stock solutions: aliquots at -20°C, generally up to one month.
Shipping conditionShips from Shanghai. Pure lipid is stable during ice-pack transport.

Formulation & study context

Literature information refers to the cited study and its particular formulation. Administration routes are research context, not clinical instructions or a guarantee of performance.

A complete product-specific formulation has not been verified. No standard ratio is substituted.

N/P ratioNot reported in the verified record
CargoNot available in the verified record
Administration routeNot available in the verified record
Animal modelNot available in the verified record
Formulation processNot available in the verified record

N/P is the molar ratio of specified lipid nitrogen groups to nucleic-acid phosphate groups. A lipid:cargo mass ratio is a different quantity and must not be used as N/P.

Stock-solution preparation table

Calculated from the product-page molecular weight: 840.28 g/mol. Volumes are final solution volumes.

Lipid mass1 mM5 mM10 mM
10 mg11.901 mL2.380 mL1.190 mL
25 mg29.752 mL5.950 mL2.975 mL
50 mg59.504 mL11.901 mL5.950 mL
100 mg119.008 mL23.802 mL11.901 mL
250 mg297.520 mL59.504 mL29.752 mL

Volume (mL) = mass (mg) × 1000 / [MW (g/mol) × concentration (mM)]. These are mathematical conversions, not measured solubility or validated solvent recommendations. Confirm solvent compatibility and the molecular weight of the exact material before use.

Open editable solution calculators →

Handling & storage

Provided that storage conditions are as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 1 year.

Wherever possible, prepare and use solutions on the same day. If stock solutions must be prepared in advance, store them as aliquots in tightly sealed vials at -20°C. Generally, these will be usable for up to one month.

Before use, and prior to opening the vial, allow the product to equilibrate to room temperature for at least 1 hour.

References

https://www.biorxiv.org/content/10.1101/2025.02.25.640222v1